DS
KRSA

DRW Securities’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

DRW Securities’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,231
Closed -$100K – 1328
2025
Q3 		$100K Buy
+6,231
New +$16.9K ﹤0.01% 1184

Other funds holding KRSA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

DRW Securities's KRSA Position: Q4 2025 in Review

DRW Securities sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q4 2025, closing a stake of 6,231 shares — an estimated $100K sold.

DRW Securities first reported a position in KRSA in Q3 2025 and held it in 1 quarter. The position peaked at $100K in Q3 2025. 18 funds tracked by Wall St. Rank hold KRSA as of Q4 2025.

  • DRW Securities reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
  • DRW Securities sold 6,231 Korsana Biosciences, Inc. Common Stock shares in Q4 2025, an estimated $100K.
  • DRW Securities first reported a position in Korsana Biosciences, Inc. Common Stock in Q3 2025 and held it in 1 quarter.
  • DRW Securities's Korsana Biosciences, Inc. Common Stock position peaked at $100K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.